A pilot study: Metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients

被引:9
|
作者
Bark, Juliana Muller [1 ,2 ,3 ]
Karpe, Avinash V. [4 ,5 ]
Doecke, James D. [6 ]
Leo, Paul [3 ,7 ]
Jeffree, Rosalind L. [8 ,9 ,10 ,11 ]
Chua, Benjamin [9 ,12 ]
Day, Bryan W. [3 ,9 ,11 ]
Beale, David J. [4 ]
Punyadeera, Chamindie [2 ,13 ,14 ,15 ]
机构
[1] Queensland Univ Technol, Fac Hlth, Ctr Biomed Technol, Sch Biomed Sci, Brisbane, Qld, Australia
[2] Griffith Univ, Griffith Inst Drug Discovery, Saliva & Liquid Biopsy Translat Lab, Brisbane, Qld, Australia
[3] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Gardens Point, Qld, Australia
[4] Environm Commonwealth Sci & Ind Res Org CSIRO, Ecosci Precinct, Dutton Pk, Qld, Australia
[5] Commonwealth Sci & Ind Res Org CSIRO, Agr & Food, Acton, ACT, Australia
[6] Royal Brisbane & Womens Hosp, Australian EHlth Res Ctr, Surg Treatment & Rehabil Serv STARS, CSIRO, Level 7, Herston, Qld, Australia
[7] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Translat Genom Grp, Woolloongabba, Australia
[8] QIMR Berghofer Med Res Inst, Herston, Qld, Australia
[9] Univ Queensland, Fac Med, Herston, Qld, Australia
[10] Royal Brisbane & Womens Hosp, Kenneth G Jamieson Dept Neurosurg, Brisbane, Qld, Australia
[11] QIMR Berghofer MRI, Cell & Mol Biol Dept, Sid Faithfull Brain Canc Lab, Brisbane, Qld, Australia
[12] Royal Brisbane & Womens Hosp, Canc Care Serv, Brisbane, Qld, Australia
[13] Griffith Univ, Menzies Hlth Inst, Southport, Qld, Australia
[14] Translat Res Inst, Woolloongabba, Qld, Australia
[15] Griffith Inst Drug Discovery, Saliva & Liquid Biopsy Translat Lab, 46 Don Young Rd, Nathan, Qld 4111, Australia
来源
CANCER MEDICINE | 2023年 / 12卷 / 10期
基金
英国医学研究理事会;
关键词
blood; glioblastoma; lipids; metabolites; metabolomics; saliva; ARGININE DEPRIVATION; CANCER; BIOSYNTHESIS; GLYCOLYSIS; CHALLENGES; BIOMARKERS; PROTEIN; GROWTH; TUMORS; CELLS;
D O I
10.1002/cam4.5857
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Despite aggressive treatment, more than 90% of glioblastoma (GBM) patients experience recurrences. GBM response to therapy is currently assessed by imaging techniques and tissue biopsy. However, difficulties with these methods may cause misinterpretation of treatment outcomes. Currently, no validated therapy response biomarkers are available for monitoring GBM progression. Metabolomics holds potential as a complementary tool to improve the interpretation of therapy responses to help in clinical interventions for GBM patients.Methods: Saliva and blood from GBM patients were collected pre and postoperatively. Patients were stratified conforming their progression-free survival (PFS) into favourable or unfavourable clinical outcomes (>9 months or PFS <= 9 months, respectively). Analysis of saliva (whole-mouth and oral rinse) and plasma samples was conducted utilising LC-QqQ-MS and LC-QTOF-MS to determine the metabolomic and lipidomic profiles. The data were investigated using univariate and multivariate statistical analyses and graphical LASSO-based graphic network analyses.Results: Altogether, 151 metabolites and 197 lipids were detected within all saliva and plasma samples. Among the patients with unfavourable outcomes, metabolites such as cyclic-AMP, 3-hydroxy-kynurenine, dihydroorotate, UDP and cis-aconitate were elevated, compared to patients with favourable outcomes during pre-and post-surgery. These metabolites showed to impact the pentose phosphate and Warburg effect pathways. The lipid profile of patients who experienced unfavourable outcomes revealed a higher heterogeneity in the abundance of lipids and fewer associations between markers in contrast to the favourable outcome group.Conclusion: Our findings indicate that changes in salivary and plasma metabolites in GBM patients can potentially be employed as less invasive prognostic biomarkers/biomarker panel but validation with larger cohorts is required.
引用
收藏
页码:11427 / 11437
页数:11
相关论文
共 50 条
  • [21] Plasma Metabolic Profiling in Patients With Silicosis and Asbestosis
    Zhou, Mi
    Xue, Changjiang
    Fan, Yali
    Wu, Na
    Ma, Jing
    Ye, Qiao
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2021, 63 (09) : 787 - 793
  • [22] Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients
    Zhang, Maochen
    Xu, Fei
    Ni, Weiqiong
    Qi, Weixiang
    Cao, Weiguo
    Xu, Cheng
    Chen, Jiayi
    Gao, Yunsheng
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (09) : 5450 - 5458
  • [23] Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients
    Evans, Sydney M.
    Putt, Mary
    Yang, Xiang-Yang
    Lustig, Robert A.
    Martinez-Lage, Maria
    Williams, Dewight
    Desai, Arati
    Wolf, Ronald
    Brem, Steven
    Koch, Cameron J.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 127 (02) : 391 - 400
  • [24] Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series
    Gurrieri, Lorena
    Mercatali, Laura
    Ibrahim, Toni
    Fausti, Valentina
    Dall'Agata, Monia
    Riva, Nada
    Ranallo, Nicoletta
    Pasini, Giuseppe
    Tazzari, Marcella
    Foca, Flavia
    Bartolini, Daniela
    Riccioni, Luca
    Cavatorta, Chiara
    Morigi, Federico Paolo
    Bulgarelli, Jenny
    Cocchi, Claudia
    Ghini, Virginia
    Tosatto, Luigino
    Martinelli, Giovanni
    Pession, Andrea
    Ridolfi, Laura
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (1) : 55 - 64
  • [25] A Hematological-Related Prognostic Scoring System for Patients With Newly Diagnosed Glioblastoma
    Zhao, Chao
    Li, Long-Qing
    Yang, Feng-Dong
    Wei, Ruo-Lun
    Wang, Min-Kai
    Song, Di-Xiang
    Guo, Xiao-Yue
    Du, Wei
    Wei, Xin-Ting
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [26] Metabolic profiling of seminal plasma from teratozoospermia patients
    Mehrparvar, Bahareh
    Chashmniam, Saeed
    Nobakht, Fatemeh
    Amini, Mehdi
    Javidi, Amin
    Minai-Tehrani, Arash
    Arjmand, Babak
    Gilany, Kambiz
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 178
  • [27] NMR-based plasma metabolic profiling in patients with unstable angina
    PouralijanAmiri, Mohammad
    Khoshkam, Maryam
    Madadi, Reza
    Kamali, Koorosh
    Ganji, Ghassem Faghanzadeh
    Salek, Reza
    Ramazani, Ali
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2020, 23 (03) : 311 - 320
  • [28] Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes
    Zhao, Hua
    Heimberger, Amy B.
    Lu, Zhimin
    Wu, Xifeng
    Hodges, Tiffany R.
    Song, Renduo
    Shen, Jie
    ONCOTARGET, 2016, 7 (15) : 20486 - 20495
  • [29] Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
    Ahluwalia, Manmeet S.
    Reardon, David A.
    Abad, Ajay P.
    Curry, William T.
    Wong, Eric T.
    Figel, Sheila A.
    Mechtler, Laszlo L.
    Peereboom, David M.
    Hutson, Alan D.
    Withers, Henry G.
    Liu, Song
    Belal, Ahmed N.
    Qiu, Jingxin
    Mogensen, Kathleen M.
    Dharma, Sanam S.
    Dhawan, Andrew
    Birkemeier, Meaghan T.
    Casucci, Danielle M.
    Ciesielski, Michael J.
    Fenstermaker, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (07) : 1453 - +
  • [30] Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study
    Enrico Franceschi
    Roberta Depenni
    Alexandro Paccapelo
    Mario Ermani
    Marina Faedi
    Carmelo Sturiale
    Maria Michiara
    Franco Servadei
    Giacomo Pavesi
    Benedetta Urbini
    Anna Pisanello
    Girolamo Crisi
    Michele A. Cavallo
    Claudio Dazzi
    Claudia Biasini
    Federica Bertolini
    Claudia Mucciarini
    Giuseppe Pasini
    Agostino Baruzzi
    Alba A. Brandes
    Journal of Neuro-Oncology, 2016, 128 : 157 - 162